HGH - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions | Total | Preferred Stock | Common Stock | Additional Paid-In Capital | Retained Earnings (Accumulated deficit) | Accumulated Other Comprehensive Income (Loss) | Treasury Stock |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | |
Preferred stock, shares outstanding (in shares) | | | 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Common stock, shares outstanding (in shares) | | | | 450,000,000 | | | | | |
Beginning balance at Dec. 31, 2021 | | | $ 0 | | | | | | |
Ending balance at Mar. 31, 2022 | | | 0 | | | | | | |
Beginning balance at Dec. 31, 2021 | | $ 2,977 | | $ 5 | $ 6,209 | $ (2,315) | $ (214) | $ (708) | |
Beginning balance (in shares) at Dec. 31, 2021 | | | | | | | | 27,000,000 | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Net income (loss) | | 426 | | | | 426 | | | |
Other comprehensive income (loss) | | (7) | | | | | (7) | | |
Net settlement on vesting of restricted stock | | (4) | | | (4) | | | | |
Stock-based compensation charges | | 28 | | | 28 | | | | |
Public Warrant exercises | | 4 | | | 4 | | | | |
Share repurchases (in shares) | | | | (35,000,000) | | | | (35,000,000) | |
Share repurchases | | (722) | | | | | | $ (722) | |
Common stock, shares outstanding, ending (in shares) at Mar. 31, 2022 | | | | 415,000,000 | | | | | |
Ending balance (in shares) at Mar. 31, 2022 | | | | | | | | 62,000,000 | |
Ending balance at Mar. 31, 2022 | | 2,702 | | $ 5 | 6,237 | (1,889) | (221) | $ (1,430) | |
Beginning balance at Dec. 31, 2021 | | | 0 | | | | | | |
Ending balance at Sep. 30, 2022 | | | $ 0 | | | | | | |
Beginning balance at Dec. 31, 2021 | | 2,977 | | $ 5 | 6,209 | (2,315) | (214) | $ (708) | |
Beginning balance (in shares) at Dec. 31, 2021 | | | | | | | | 27,000,000 | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Net income (loss) | | 1,943 | | | | | | | |
Other comprehensive income (loss) | | (145) | | | | | | | |
Common stock, shares outstanding, ending (in shares) at Sep. 30, 2022 | | | | 341,000,000 | | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | | | | | | | 137,000,000 | |
Ending balance at Sep. 30, 2022 | | 2,761 | | $ 5 | 6,308 | (372) | (359) | $ (2,821) | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | |
Preferred stock, shares outstanding (in shares) | | | 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Common stock, shares outstanding (in shares) | | | | 415,000,000 | | | | | |
Beginning balance at Mar. 31, 2022 | | | $ 0 | | | | | | |
Ending balance at Jun. 30, 2022 | | | $ 0 | | | | | | |
Beginning balance at Mar. 31, 2022 | | 2,702 | | $ 5 | 6,237 | (1,889) | (221) | $ (1,430) | |
Beginning balance (in shares) at Mar. 31, 2022 | | | | | | | | 62,000,000 | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Net income (loss) | | 940 | | | | 940 | | | |
Other comprehensive income (loss) | | (59) | | | | | (59) | | |
Stock-based compensation charges | | 36 | | | 36 | | | | |
Public Warrant exercises | | 1 | | | 1 | | | | |
Share repurchases (in shares) | | | | (47,000,000) | | | | (47,000,000) | |
Share repurchases | | (891) | | | | | | $ (891) | |
Common stock, shares outstanding, ending (in shares) at Jun. 30, 2022 | | | | 368,000,000 | | | | | |
Ending balance (in shares) at Jun. 30, 2022 | | | | | | | | 109,000,000 | |
Ending balance at Jun. 30, 2022 | | 2,729 | | $ 5 | 6,274 | (949) | (280) | $ (2,321) | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | |
Preferred stock, shares outstanding (in shares) | | | 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Common stock, shares outstanding (in shares) | | | | 368,000,000 | | | | | |
Ending balance at Sep. 30, 2022 | | | $ 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Net income (loss) | | 577 | | | | 577 | | | |
Other comprehensive income (loss) | | (79) | | | | | (79) | | |
Stock-based compensation charges | | 33 | | | 33 | | | | |
Public Warrant exercises | | 1 | | | 1 | | | | |
Share repurchases (in shares) | | | | (27,000,000) | | | | (28,000,000) | |
Share repurchases | | (500) | | | | | | $ (500) | |
Common stock, shares outstanding, ending (in shares) at Sep. 30, 2022 | | | | 341,000,000 | | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | | | | | | | 137,000,000 | |
Ending balance at Sep. 30, 2022 | | $ 2,761 | | $ 5 | 6,308 | (372) | (359) | $ (2,821) | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | |
Preferred stock, shares outstanding (in shares) | | | 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Common stock, shares outstanding (in shares) | | | | 341,000,000 | | | | | |
Preferred stock, shares outstanding (in shares) | | 0 | 0 | | | | | | |
Common stock, shares outstanding (in shares) | | 323,483,178 | | 323,000,000 | | | | | |
Beginning balance at Dec. 31, 2022 | | $ 0 | $ 0 | | | | | | |
Ending balance at Mar. 31, 2023 | | | 0 | | | | | | |
Beginning balance at Dec. 31, 2022 | | $ 2,645 | | $ 5 | 6,326 | (256) | (294) | $ (3,136) | |
Beginning balance (in shares) at Dec. 31, 2022 | | 155,430,884 | | | | | | 155,000,000 | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Net income (loss) | | $ 196 | | | | 196 | | | |
Other comprehensive income (loss) | | 14 | | | | | 14 | | |
Net settlement on vesting of restricted stock | | (1) | | | (1) | | | | |
Stock-based compensation charges | | 21 | | | 21 | | | | |
Share repurchases (in shares) | [1],[2] | | | (5,000,000) | | | | (6,000,000) | |
Share repurchases | [1],[2] | (101) | | | | | | $ (101) | |
Common stock, shares outstanding, ending (in shares) at Mar. 31, 2023 | | | | 318,000,000 | | | | | |
Ending balance (in shares) at Mar. 31, 2023 | | | | | | | | 161,000,000 | |
Ending balance at Mar. 31, 2023 | | 2,774 | | $ 5 | 6,346 | (60) | (280) | $ (3,237) | |
Beginning balance at Dec. 31, 2022 | | 0 | 0 | | | | | | |
Ending balance at Sep. 30, 2023 | | 0 | $ 0 | | | | | | |
Beginning balance at Dec. 31, 2022 | | $ 2,645 | | $ 5 | 6,326 | (256) | (294) | $ (3,136) | |
Beginning balance (in shares) at Dec. 31, 2022 | | 155,430,884 | | | | | | 155,000,000 | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Net income (loss) | | $ 964 | | | | | | | |
Other comprehensive income (loss) | | $ (29) | | | | | | | |
Common stock, shares outstanding, ending (in shares) at Sep. 30, 2023 | | 308,798,093 | | 309,000,000 | | | | | |
Ending balance (in shares) at Sep. 30, 2023 | | 170,455,524 | | | | | | 170,000,000 | |
Ending balance at Sep. 30, 2023 | | $ 3,390 | | $ 5 | 6,389 | 708 | (323) | $ (3,389) | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | |
Preferred stock, shares outstanding (in shares) | | | 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Common stock, shares outstanding (in shares) | | | | 318,000,000 | | | | | |
Beginning balance at Mar. 31, 2023 | | | $ 0 | | | | | | |
Ending balance at Jun. 30, 2023 | | | $ 0 | | | | | | |
Beginning balance at Mar. 31, 2023 | | 2,774 | | $ 5 | 6,346 | (60) | (280) | $ (3,237) | |
Beginning balance (in shares) at Mar. 31, 2023 | | | | | | | | 161,000,000 | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Net income (loss) | | 139 | | | | 139 | | | |
Other comprehensive income (loss) | | 4 | | | | | 4 | | |
Stock-based compensation charges | | 22 | | | 22 | | | | |
Public Warrant exercises | [1] | 1 | | | 1 | | | | |
Share repurchases (in shares) | [1] | | | (6,000,000) | | | | (6,000,000) | |
Share repurchases | [1] | (101) | | | | | | $ (101) | |
Common stock, shares outstanding, ending (in shares) at Jun. 30, 2023 | | | | 312,000,000 | | | | | |
Ending balance (in shares) at Jun. 30, 2023 | | | | | | | | 167,000,000 | |
Ending balance at Jun. 30, 2023 | | 2,839 | | $ 5 | 6,369 | 79 | (276) | $ (3,338) | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | |
Preferred stock, shares outstanding (in shares) | | | 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Common stock, shares outstanding (in shares) | | | | 312,000,000 | | | | | |
Ending balance at Sep. 30, 2023 | | 0 | $ 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Net income (loss) | | 629 | | | | 629 | | | |
Other comprehensive income (loss) | | (47) | | | | | (47) | | |
Net settlement on vesting of restricted stock | | (2) | | | (2) | | | | |
Stock-based compensation charges | [1] | 22 | | | 22 | | | | |
Share repurchases (in shares) | | | | (3,000,000) | | | | (3,000,000) | [1] |
Share repurchases | [1] | $ (51) | | | | | | $ (51) | |
Common stock, shares outstanding, ending (in shares) at Sep. 30, 2023 | | 308,798,093 | | 309,000,000 | | | | | |
Ending balance (in shares) at Sep. 30, 2023 | | 170,455,524 | | | | | | 170,000,000 | |
Ending balance at Sep. 30, 2023 | | $ 3,390 | | $ 5 | $ 6,389 | $ 708 | $ (323) | $ (3,389) | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | |
Preferred stock, shares outstanding (in shares) | | 0 | 0 | | | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | | | | |
Common stock, shares outstanding (in shares) | | 308,798,093 | | 309,000,000 | | | | | |
| |
[1]Also see Note 8, "Public Warrants, Equity and Earnings (Loss) Per Common Share – Hertz Global."[2]The amounts presented herein may be rounded to agree to amounts in the unaudited condensed consolidated balance sheet. | |